KAT5 and metastatic melanoma: As displayed in Figure 1, BRAF and MMP2 proteins showed a progressive increase from Stage I to Stage IV (Figure 1A, 1B), whereas Tip60 loss is most pronounced in metastatic melanoma (Stage III and IV) as compared to primary melanomas (Stages I and II) (Figure 1F).